| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 01/12/2005 | CN1184203C 1-benzyl-4-[(5,6-dimethoxy-2-fluoro-1-indanon)-2-yl] methylpiperidine |
| 01/12/2005 | CN1183963C Method for treatment of patients afflicted with multile sclerosis using consensus interferon |
| 01/12/2005 | CN1183962C Preparation capable of mobilization of activity |
| 01/12/2005 | CN1183924C Application of warm soaked extraction of polygonum multiflorum |
| 01/12/2005 | CN1183915C Medicine preparation for inhibiting immune deficiency syndrome virus infection and proliferation and its application |
| 01/12/2005 | CN1183907C Imidazoline compound, preparing process thereof and pharmaceutical composition contg. same |
| 01/12/2005 | CN1183841C Anti-fatigue male's health tea its production process |
| 01/11/2005 | US6841701 Inhibitors for the blood-clotting factor Xa |
| 01/11/2005 | US6841698 Aminopropylphosphinic acids |
| 01/11/2005 | US6841684 Imidiazoles having reduced side effects |
| 01/11/2005 | US6841682 Prevent binding of adrenergenic receptors |
| 01/11/2005 | US6841674 N-heterocyclic derivatives as NOS inhibitors |
| 01/11/2005 | US6841673 Enzyme inhibitors; antiinflammatory agents; rheumatic diseases; antidiabetic agents |
| 01/11/2005 | US6841571 Compounds useful as reversible inhibitors of cysteine proteases |
| 01/11/2005 | US6841568 Inducing contraception, treat progesterone-related carcinomas and adenocarcinomas; hormone replacement therapy |
| 01/11/2005 | US6841567 Cyclic substituted fused pyrrolocarbazoles and isoindolones |
| 01/11/2005 | US6841566 Viral polymerase inhibitors |
| 01/11/2005 | US6841564 Tri-aryl-substituted-ethane PDE4 inhibitors |
| 01/11/2005 | US6841563 Aryloxy propanolamines for improving livestock production |
| 01/11/2005 | US6841558 Aza-and polyaza-naphthalenyl carboxamides useful as HIV intergrase inhibitors |
| 01/11/2005 | US6841554 Crystalline salts of 7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl]-(3r,5s)-3,5-dihydroxyhept-6-enoic acid |
| 01/11/2005 | US6841551 Administering substance P receptor antagonist selected from the group consisting of L 742694, L 758298, and LY 303241, a non-toxic magnesium compound and a pharmaceutically acceptable vehicle |
| 01/11/2005 | US6841550 Benzoxazine and benzothiazine derivatives and their use in medicines |
| 01/11/2005 | US6841549 Condensed imidazole compounds and a therapeutic agent for diabetes mellitus |
| 01/11/2005 | US6841546 Prevention of microorganismal infections; obtain sample of microorganism, incubate with tetracycline compound, monitor propagation of microorganism, reduced propagation indicates effective fungicide |
| 01/11/2005 | US6841545 Heat resistance; anticancer drug |
| 01/11/2005 | US6841177 Pharmacological activities of curcuma longa extracts |
| 01/11/2005 | CA2342072C Kunitz domain polypeptide zkun6 |
| 01/11/2005 | CA2284051C Pharmaceutical composition for oral administration of a n-piperidino-3-pyrazolecarboxamide derivative, its salts and their solvates |
| 01/11/2005 | CA2269128C Piperazino derivatives as neurokinin antagonists |
| 01/11/2005 | CA2248235C Use of honey as an agent to reduce the adhesion of microorganisms |
| 01/11/2005 | CA2241244C Use of inhibitors of the activity of retinoic acid for treating sensitive skin and/or acute damage induced by uv radiation |
| 01/11/2005 | CA2151443C Cycloheptimidazole derivatives, method of manufacturing the same and therapeutic agents containing these compounds |
| 01/11/2005 | CA2104909C Decahydroisoquinolines as excitatory amino acid receptor antagonists |
| 01/06/2005 | WO2005000829A1 Cannabinoid receptor modulator |
| 01/06/2005 | WO2005000825A1 Thiazolimine compound and oxazolimine compound |
| 01/06/2005 | WO2005000798A1 Heterocyclic methyl sulfone derivative |
| 01/06/2005 | WO2005000793A1 2-substituted cycloalkylcarboxylic acid derivative |
| 01/06/2005 | WO2005000791A1 2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic ester derivative |
| 01/06/2005 | WO2005000790A1 2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid derivative |
| 01/06/2005 | WO2005000778A1 Hsp90 FAMILY PROTEIN INHIBITORS |
| 01/06/2005 | WO2005000356A1 Remedy for urinary tract diseases |
| 01/06/2005 | WO2005000354A1 Preventive/remedy for urinary disturbance |
| 01/06/2005 | WO2005000353A1 Serum cholesterol lowering agnet or preventive or therapeutic agent for atherosclerosis |
| 01/06/2005 | WO2005000316A1 External preparation for improving coital function |
| 01/06/2005 | WO2005000287A1 External preparation for athlete's foot treatment |
| 01/06/2005 | WO2005000195A2 A pretreatment or post exposure treatment for exposure to a toxic substance by pulmonary delivery (inhaler) of a bioscavenger |
| 01/06/2005 | WO2004089417A9 Drug-enclosing multilayer structure particulate and process for producing the same |
| 01/06/2005 | WO2004062657A8 Acylated 4-amidino- and 4-guanidinobenzylamines for the inhibition of plasma kallikrein |
| 01/06/2005 | WO2003050255A3 Nucleic acid and corresponding protein entitled 193p1e1b useful in treatment and detection of cancer |
| 01/06/2005 | WO2003042177A8 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5) |
| 01/06/2005 | US20050004510 Noninvasive vascular therapy |
| 01/06/2005 | US20050004382 Meiosis regulating compounds |
| 01/06/2005 | US20050004363 4-oxoimidazolidine-2-spiropiperidine derivatives |
| 01/06/2005 | US20050004360 Compounds and methods for modulation of estrogen receptors |
| 01/06/2005 | US20050004348 Sodium transport protein for use as tool in identifying modulator for treatment of hyperphosphatemia or hypophosphatemia |
| 01/06/2005 | US20050004217 Utilizing cistaceous plant extract; safe, side effect free; |
| 01/06/2005 | US20050004205 Such as 1-[N alpha -(1'-Acetoxyethoxycarbonyl)-N omega -(pyrazinyl-2-carbonyl)-L-ornithinyl]-pyrrolidine-2-carbonitrile; impaired glucose tolerance, type II diabetes, hypoglycaemia |
| 01/06/2005 | US20050004204 2-Iminopyrrolidine derivatives |
| 01/06/2005 | US20050004202 Such as 3-[1-(3-methoxypropyl )-1H-indazol-3-yl]-4-[1-(3-pyridinyl )-1H-indol-3-yl]-1H-pyrrole-2,5-dione; protein kinase C and/or glycogen synthase kinase-3 diseases |
| 01/06/2005 | US20050004197 Thrombin receptors antagonists; oral efficacy |
| 01/06/2005 | US20050004183 for preventing, Syndrome X, diabetes, hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension, atherosclerosis, and other disorders related to Syndrome X and cardiovascular diseases; peroxisome proliferator activated receptor (PPAR) |
| 01/06/2005 | US20050004175 Xanthine oxidase inhibitors; hyperuricemia and gout; such as 3-(4-isobutoxy-3-nitrophenyl)-5-(2-methyl-4-pyridyl)-1,2,4-triazole |
| 01/06/2005 | US20050004171 Increasing blood absorption of proton pump inhibitor; adjusting stomach gastric fluid pH with buffering agent to inhibit acid degradation |
| 01/06/2005 | US20050004170 Substituted 4-phenyl-4-[1h-imidazol-2-yl]-piperidine derivatives for reducing ischaemic damage |
| 01/06/2005 | US20050004167 Such as dibenzofuran-2-carboxylic acid 2-(phenylsulfonyl)hydrazide |
| 01/06/2005 | US20050004165 Composition and method for modulating BAR/FXR receptor activity |
| 01/06/2005 | US20050004154 1,2,8-Triazaspiro{decan-4-one derivatives useful for the treatment of orl-1receptor mediated disorders |
| 01/06/2005 | US20050004149 Pyrimidine compound and medicinal composition thereof |
| 01/06/2005 | US20050004142 furo(2,3-d)pyrimidine and thieno(2,3-d)pyrimidine compounds for treating cancer and hyperproliferative diseases; receptor tyrosine kinase inhibitors |
| 01/06/2005 | US20050004140 Such as n-(4-fluorobenzyl)-6-(4-methyl-1H-imidazol-1-yl)pyrazin-2-amine; protein kinase associated disease states |
| 01/06/2005 | US20050004134 Adenosine antagonists; having 6-oxo-1,6-dihydro-3-pynidazinyl functionality; synthesis |
| 01/06/2005 | US20050004133 Inhibiting ligand gated ion channel vanilloid receptor (VR1); pain relievers; such as 6-(3,4-dichloro-phenyl)-N-(2-oxo-2,3-dihydro-1H-benzoimidazol-5-yl)-nicotinamide |
| 01/06/2005 | US20050004132 Pain, immune diseases, inflammatory disorders; low toxicity; such as 1-[2-(3-(4-Pyridyl)phenyl)ethyl]-4-(3-(trifluoromethyl)phenyl)-1,2,3,6-tetrahydropyridine 1-oxide |
| 01/06/2005 | US20050004128 4-(6-chloro-, methyl- or thien-3-yl-oxazolo[4,5-b]pyrid-2-yl)-1,4-diazabicyclo[3.2.2]nonane or salts; nicotinic receptor associated disorders; cholinergic agents |
| 01/06/2005 | US20050004126 Method of determining potential allosterically-binding matrix metalloproteinase inhibitors |
| 01/06/2005 | US20050004124 Synergistic mixture; antidiabetic agents; antiischemic agents |
| 01/06/2005 | US20050004119 Trypsin like serine protease enzyme inhibitors |
| 01/06/2005 | US20050004116 Triazole inhibitors of type 2 methionine aminopeptidase |
| 01/06/2005 | US20050004110 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease |
| 01/06/2005 | US20050004103 Vasopressin active material; antidiabetic agents; diuretics; bioavailability |
| 01/06/2005 | US20050004099 Spiroazabicyclic heterocyclic compounds |
| 01/06/2005 | US20050004096 Indole derivatives, process for producing the same and drugs containing the same as the active ingredient |
| 01/06/2005 | US20050004082 Ether compounds |
| 01/06/2005 | US20050004077 Antidiabetic agents ; bioavailability |
| 01/06/2005 | US20050004061 Immunostimulatory nucleic acid molecules |
| 01/06/2005 | US20050004055 Synergistic process; electrical stimulation; administering hyaluronidase |
| 01/06/2005 | US20050004041 Obtained by hydrolysis of casein; hypotensive agents; foods, drugs |
| 01/06/2005 | US20050004037 Osteogenic growth oligopeptides as stimulants of hematopoiesis |
| 01/06/2005 | US20050004035 Antiinflammatory agents; multiple sclerosis; inflamamtory bowel disorders; antitumor agents; sepsis |
| 01/06/2005 | US20050004018 Use of antitumoral compound in cancer therapy |
| 01/06/2005 | US20050004016 Quantitative analysis of amino acid sequences; genetic engineering |
| 01/06/2005 | US20050004010 Complex with antitumor agents; therapy, diagnosis |
| 01/06/2005 | US20050003493 Kit comprising immunoblobulins which bind the bioactive, three-dimensional epitope of parathyroid hormone for use in classifying hypercalcemic disorders |
| 01/06/2005 | US20050003492 Novel polypeptide |
| 01/06/2005 | US20050003481 Novel glutamic acid receptor and utilization thereof |
| 01/06/2005 | US20050003463 Method and nucleic acids for the analysis of colorectal cell proliferative disorders |
| 01/06/2005 | US20050003453 G-CSF analog compositions and methods |
| 01/06/2005 | US20050003451 Immunoglobulin for use in diagnosis, prevention and treatment of infection, autoimmune, inflammatory and cell proliferative diseases; immunotherapy |
| 01/06/2005 | US20050003412 Protein activator of superoxide production for use in treatment and prevention of cancer, psoriasis, prostatic hypertrophy, benign prostatic hypertrophy and cardiovascular disease |